Global Vascular Stents Market Size By Type (BMS, BVS), By Application (Hospital, Cardiology Center), By Region, And Segment Forecasts, 2023 to 2032

lobal Vascular Stents Market Report Description

The Global Vascular Stents Market was valued at USD 13.4 billion in 2023 and is projected to reach USD 24.6 billion by 2031, growing at a CAGR of 7.9% during the forecast period from 2023 to 2031. The rising prevalence of cardiovascular diseases, expanding geriatric population, and continuous technological innovations in stenting techniques are key contributors to market growth. Vascular stents play a crucial role in the treatment of coronary artery disease and peripheral artery disease, providing mechanical support to blood vessels and preventing restenosis. Increasing demand for minimally invasive procedures, along with rising healthcare investments globally, is expected to sustain the market’s upward trajectory.

Drivers:

Rising Prevalence of Cardiovascular Diseases:

Cardiovascular diseases remain the leading cause of mortality worldwide. The increasing burden of coronary and peripheral artery diseases is driving the demand for vascular stenting procedures.

Growth in Geriatric Population:

The aging global population is more prone to vascular disorders, necessitating interventional procedures such as angioplasty and stenting. This demographic trend is fueling the growth of the vascular stents market.

Technological Advancements in Stents:

Innovations such as drug-eluting stents (DES), bioresorbable stents, and dual-therapy stents have improved efficacy and reduced complication rates, encouraging greater adoption.

Restraints:

Stringent Regulatory Approval Processes:

The vascular stents market is subject to rigorous regulatory standards, which can delay product approvals and market entry, limiting growth potential for new entrants.

Risk of Complications Post-Implantation:

Stent thrombosis, restenosis, and other post-implantation complications continue to pose challenges, affecting both patient outcomes and overall market trust.

Opportunity:

Expansion in Emerging Markets:

Countries across Asia-Pacific, Latin America, and the Middle East are witnessing increased healthcare infrastructure development and rising awareness about cardiovascular interventions, offering lucrative growth opportunities for market players.

Integration of AI and Imaging Technologies:

The integration of artificial intelligence and high-definition imaging in interventional cardiology is optimizing stent selection and placement, opening new avenues for personalized medicine and improved outcomes.

Market by System Type Insights:

Among system types, drug-eluting stents (DES) dominated the market in 2023, accounting for the largest revenue share. DES are preferred for their ability to significantly reduce the risk of restenosis by releasing antiproliferative drugs. The bioresorbable vascular stents segment, although nascent, is expected to register the highest CAGR due to their long-term safety benefits and increasing clinical adoption.

Market by End-use Insights:

By end-use, hospitals emerged as the dominant segment in 2023, holding over 60% of the market share. Hospitals continue to be the primary centers for interventional cardiology procedures, equipped with advanced technologies and expert personnel. Ambulatory surgical centers (ASCs) are also gaining traction due to shorter procedure times, cost-effectiveness, and enhanced patient convenience.

Market by Regional Insights:

Geographically, North America led the market in 2023, driven by the high prevalence of cardiovascular diseases, sophisticated healthcare systems, and early adoption of new stenting technologies. Asia-Pacific is projected to be the fastest-growing region, supported by rapid healthcare infrastructure development, increasing government initiatives for cardiac care, and a rising patient population in countries such as China and India.

Competitive Scenario:

Key players in the Global Vascular Stents Market include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BIOTRONIK, Cook Medical, B. Braun Melsungen AG, Cordis, MicroPort Scientific Corporation, and Lepu Medical Technology. These companies are heavily investing in R&D, strategic partnerships, and market expansion efforts to strengthen their competitive positions.

Recent Developments Include:

2023: Abbott launched its next-generation drug-eluting stent with enhanced deliverability and improved clinical outcomes.

2024: Boston Scientific announced a strategic acquisition of a vascular technology start-up to expand its stent portfolio.

2025: Terumo Corporation introduced a bioresorbable polymer-based stent, aimed at long-term vascular healing.

Scope of Work – Global Vascular Stents Market

Report Metric Details

Market Size (2023) USD 13.4 billion

Projected Market Size (2031) USD 24.6 billion

CAGR (2023-2031) 7.9%

Market Segments By System Type (Bare Metal, Drug-Eluting, Bioresorbable), By End-use (Hospitals, ASCs)

Growth Drivers Rising CVD prevalence, aging population, and technological advancements

Opportunities Expansion in emerging markets, AI & imaging integration

Key Market Developments:

Abbott (2023): Rolled out a high-precision stent delivery system with enhanced navigation in complex anatomies.

Boston Scientific (2024): Expanded presence in Southeast Asia with new production and R&D facilities.

Medtronic (2025): Received